Stock listing

Cantargia Ab

Selected listing: CANTA · OMXSTO · SEK · SE

Cantargia Ab (Stockholm:CANTA), Health Technology. Latest release Aug 4, 2026: Cantargia to Host Q2 2026 Interim Results Conference Call.

CANTA:OMXSTOSEKSEUpdated October 3, 2026

Ticker: Stockholm:CANTA
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Stockholm
Currency: SEK

About Cantargia Ab

Cantargia Ab is a public company listed on the Swedish market under the ticker CANTA. Cantargia focuses on developing innovative treatments for cancer and inflammatory diseases.

Latest news from Cantargia Ab

Cantargia to Host Q2 2026 Interim Results Conference Call

August 4, 2026

Cantargia : Cantargia Announces Changes in Number of Shares and Votes

July 31, 2026

Cantargia Announces Changes in Number of Shares and Votes

July 31, 2026

Cantargia Announces Publication of Data Supporting IL1RAP as a Therapeutic Target and Predictive Biomarker in PDAC

June 26, 2026

Cantargia announces outcome in rights issue and resolves on a directed issue of warrants to Fenja Capital

June 23, 2026

All Cantargia Ab news →

Events

Replays

Cantargia AB (publ) (CANTA) Q2 2026 Earnings Call
Wed, Aug 19, 2026 · 09:00 AM ET
Watch
Cantargia AB (publ) (CANTA) Q1 2026 Earnings Call
Tue, May 19, 2026 · 09:00 AM ET
Watch
Cantargia AB (publ) (CANTA) Q4 2025 Earnings Call
Fri, Feb 20, 2026 · 09:00 AM ET
Watch

Research Cantargia Ab

Cantargia Ab company profile

View the public company page for Cantargia Ab on 6ix.

Cantargia Ab news

Read company news and market updates connected to Cantargia Ab.

Cantargia Ab investor events

Find investor webinars, events, and replay context for Cantargia Ab.